Skip to main content
Artificial Intelligence

Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial.

| Source: Nature medicine

Nightmares are a hallmark of post-traumatic stress disorder (PTSD), yet pharmacological treatments remain limited. Here we conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of dronabinol (BX-1; Δ9-tetrahydrocannabinol (THC)) for PTSD-related nightmares. Adults with PTSD and recurrent nightmares were randomly assigned to receive dronabinol (2.5-15 mg) or placebo, once daily before bedtime, for 10 weeks. The primary endpoin

Nightmares are a hallmark of post-traumatic stress disorder (PTSD), yet pharmacological treatments remain limited. Here we conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of dronabinol (BX-1; Δ9-tetrahydrocannabinol (THC)) for PTSD-related nightmares. Adults with PTSD and recurrent nightmares were randomly assigned to receive dronabinol (2.5-15 mg) or placebo, once daily before bedtime, for 10 weeks. The primary endpoint was change from baseline to week 10 in the Clinician-Administered PTSD Scale for DSM-IV (CAPS-IV) B2 item assessing nightmare frequency and intensity. A total of 171 patients underwent randomization (mean age, 37.9 ± 12.8 years; 79.3% female), with 87 assigned to dronabinol and 84 to placebo. At week 10, reduction in CAPS-IV B2 scores was significantly greater with dronabinol than with placebo (between-group difference -1.50; 95% confidence interval -2.28 to -0.71; Cohen's d = 0.65; P < 0.001). Adverse events occurred in 78 patients (89.7%) receiving dronabinol and 64 (77.1%) receiving placebo. Treatment discontinuation due to adverse events occurred in five (5.7%) and six (7.2%) patients, respectively. Serious adverse events occurred in seven patients (8.0%) receiving dronabinol and in none receiving placebo. This trial provides evidence that dronabinol reduces the frequency and intensity of PTSD-related nightmares, although long-term efficacy and safety require further evaluation. ClinicalTrials.gov: NCT04448808 .

Read the original source →

Related Stories

Artificial Intelligence

Where intention goes, responsibility flows: Grounding AI accountability in the machine learning paradigm.

An opening salvo of lawsuits in US courts has begun holding AI companies accountable through independent doctrinal routes: Product liability and agency law cut as swords, while the shields of Section 230 immunity and First Amendment doctrine begin to crack. This Perspective points out that these converging paths share a unifying principle, built on the very engineering architecture of machine learning (ML) itself. Every ML system, across all variants, is constituted by a human-specified objectiv

Continue reading
Artificial Intelligence

Protein resource allocation across subcellular compartments revealed by large-scale absolute quantitative proteomics in yeast.

Subcellular compartmentalization within complex membrane-bound organelles is a hallmark of eukaryal life, enabling metabolic specialization through spatial segregation. Here, we compiled a dataset encompassing 300 absolute quantitative proteomes, the largest to date, across two yeast species under diverse experimental conditions. Leveraging big data analysis, formula fitting, and machine learning, quantitative correlations among protein abundance, resource allocation, and cellular phenotypes wer

Continue reading
Artificial Intelligence

Quantifying ancient architecture: Stone-level machine learning reveals architectural variation and settlement growth at Shivta.

Built environments provide durable evidence for how ancient settlements were organized, expanded, and transformed over time. Yet quantitative approaches to documenting architectural variability are generally labor-intensive, limited to individual structures, or dependent on aggregate volumetric estimates. We present a scalable, machine-learning-based framework that shifts the unit of analysis to the individual building stone and combines two complementary datasets: low-altitude drone imagery of

Continue reading
Artificial Intelligence

In-context learning as a retraining-free paradigm for constitutive modeling.

Constitutive modeling is fundamental to computational solid mechanics, yet most existing approaches remain material-specific and require retraining or recalibration when materials change. Here we introduce In-Context Modeling (ICM), a retraining-free paradigm for constitutive modeling that infers constitutive behavior from physical context rather than material-specific optimization. Using hyperelasticity as a testbed, we demonstrate that ICM can be trained once on equilibrium deformation fields

Continue reading
Artificial Intelligence

Data-driven discovery and rapid, direct synthesis of MXenes.

MXenes are a rapidly expanding family of two-dimensional transition metal carbides and nitrides, yet scalable synthesis routes remain limited and historical reports suggest a broader, largely unexplored chemical space. We used machine learning-assisted database mining to uncover hidden multilayer MXenes. Screening reveals 33 previously synthesized but unrecognized MXene candidates. Guided by these findings, we synthesized seven multilayer MXenes using a rapid, scalable self-propagating high-temp

Continue reading